can i write off semaglutide on taxes Yes, it is true. The Internal Revenue Service (IRS) recognizes that obesity is a disease, and certain expenses related to obesity treatments qualify as tax-deductible medical expenses. According to IRS guidelines What is a Tax Write-Off?

[DOI] [PubMed] [Google Scholar] Dufresne M., Thomas A., Breault-Turcot J., Masson J

Pharmaceutical semaglutide (Wegovy/Ozempic): Retail price: $1,000-1,500 per month With insurance: $25-$300 per month (if covered) Annual cost: $12,000-18,000 without insurance Insurance coverage: Inconsistent, many plans don't cover weight loss Pharmaceutical tirzepatide (Zepbound/Mounjaro): Retail price: $1,000-1,500 per month With insurance: $25-$300 per month (if covered) Annual cost: $12,000-18,000 without insurance Insurance coverage: Even less consistent than semaglutide Research peptide semaglutide: Cost: $150-250 per month at therapeutic doses No insurance involvement Annual cost: $1,800-3,000 Must reconstitute yourself from powder Research peptide tirzepatide: Cost: $200-300 per month at therapeutic doses No insurance involvement Annual cost: $2,400-3,600 Must reconstitute yourself from powder Research peptides are 80-90% cheaper than pharmaceutical versions

The tiers: beginner 250 mcg twice daily, moderate 500 mcg once daily, aggressive 500 mcg twice daily

Dysregulation of Adipose Glutathione Peroxidase 3 in Obesity Contributes to Local and Systemic Oxidative Stress

That absolute risk is still small, but the signal is real enough to justify gastric emptying scintigraphy if symptoms persist beyond eight weeks at a stable Wegovy dose

Semaglutide has an elimination half-life of approximately 168 hours, while tirzepatide's half-life is approximately 116-120 hours, both supporting once-weekly dosing